Eugenio Galli

23PUBLICATIONS
59CO-AUTHORS
Haematological tumoursCardiology (incl. cardiovascular diseases)Tumour immunologyElectrical energy generation (incl. renewables, excl. photovoltaics)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Aug 08, 2025
Routine prophylaxis with levetiracetam offers no benefit in CD19 CAR-T for LBCL: a multicenter propensity-matched study.

Eugenio Galli, Roberta Di Blasi, Alice Di Rocco

|Jun 24, 2025
Frail is not fail: Limited impact of comorbidities on non-relapse mortality and safety in patients with LBCL treated with CAR-T.

Eugenio Galli, Roberta Di Blasi, Ilaria Pansini

|Nov 19, 2024
First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies.

Francesco Autore, A Tedeschi, G Benevolo

|Nov 14, 2024
Predicting therapy-related myeloid neoplasms after CAR-T with the Clonal Haematopoiesis Risk Score (CHRS).

Eugenio Galli, Monica Rossi, Ilaria Pansini

|Aug 27, 2024
Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT.

Urban Novak, Jarl E Mooyaart, Michael Daskalakis

|Jun 28, 2024
Coagulopathy in CAR-T: Critical concern or mere blip?

Eugenio Galli, Federica Sorà, Elena Rossi

Pageof 4

Frequent Collaborators

14 joint publications

Patrizia Chiusolo

13 joint publications

Federica Sorà

7 joint publications

Simona Sica

7 joint publications

Alberto Fresa